Multicenter Nordic Study Comparing Catheter-Directed Intervention and Systemic Thrombolysis for Acute Pulmonary Embolism
Led by Sahlgrenska University Hospital · Updated on 2026-01-21
220
Participants Needed
13
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying treatment options for adults with acute pulmonary embolism PE, a serious condition where blood clots block lung arteries. The study compares catheter-directed intervention CDI, which uses devices like mechanical thrombectomy or catheter-directed thrombolysis, to systemic thrombolysis ST with a clot-busting drug called alteplase. This observational study aims to understand how these treatments affect survival and bleeding risks within 30 days after treatment.
Participants receive either catheter-directed intervention using various devices or systemic thrombolysis with intravenous alteplase. The FlowTriever device is a common CDI method used in Sweden. The study observes current clinical practices in Nordic countries, including patients who receive standard treatments or alternative reperfusion therapies depending on their condition and available resources.
During the study, researchers will collect data on severe bleeding or death within 30 days, as well as other outcomes like recurrent PE, hospital and ICU stay duration, and heart function up to one year. Participants will be monitored through imaging, functional tests, questionnaires on quality of life and breathing difficulties, and blood biomarkers. The study lasts at least one year to evaluate both short- and long-term effects of the treatments.
CONDITIONS
Brief Title
Reperfusion Treatment in Acute Pulmonary Embolism
Research Team
F
Freyr Einarsson, MD
A
Annika Odenstedt, coordinator
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Adults aged 18 years or older, including pregnant women, with confirmed acute pulmonary embolism by CTPA, angiography, or scintigraphy
Planned for or have received treatment with catheter-directed intervention or systemic thrombolysis
Provided informed consent, or waiver applies if patient does not survive before consent can be obtained
You will not qualify if you...
Currently enrolled in an interventional catheter-directed intervention trial
Surgical embolectomy as the primary reperfusion treatment
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Up to 30 days from treatment
Participants receive reperfusion treatment for acute pulmonary embolism using catheter-directed intervention or systemic thrombolysis according to clinical practice.
1 treatment visit and follow-up visits during 30 days
Long-term Monitoring
Duration - Up to 1 year
Participants are monitored for outcomes including heart function, symptoms, quality of life, and complications for up to 1 year after treatment.
Periodic follow-up visits during 1 year
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Study of Home-Based Exercise Effects on Mobility After Pulmonary Embolism
Acutelines Biobank to Improve Early Detection and Personalized Treatment of Acute Diseases
Tracking Patient Outcomes from Emergency Admissions
Long-Term Evaluation of Aspiration Thrombectomy Using Symphony and Prodigy Systems for Arterial, Venous, and Pulmonary Blood Clots
Studying the Link Between Anti-factor Xa Activity and Blood Clots in Critically Ill ICU Patients
Study of Artificial Intelligence in Multimodal Imaging to Improve Diagnosis and Management of Pulmonary Embolism in Patients Aged 14 and Older in China
Improving Prevention of Blood Clots in Hospitalized Patients Using a System-Wide Quality Program in China
Clinical Outcomes and Treatments for Pulmonary Embolism
A Study by the Bern Acute Pulmonary Embolism Registry
Comparing Clinical Surveillance and Anticoagulation Treatment
for Low-risk Patients with Isolated Subsegmental Pulmonary Embolism
Evaluating Portable Dynamic Chest X-Ray DDR for Lung Function Diagnosis in ICU Patients
A Study on Feasibility and Improved Diagnostic Accuracy Compared to Standard Imaging
Early Detection of Deep Vein Thrombosis in Critically Ill ICU Patients Using Twice Weekly Ultrasound Compared to Standard Care
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Reperfusion treatment strategies in acute pulmonary embolism: Study protocol for a multicenter prospective observational study in the Nordic countries (PE-NORDIC).
Freyr Einarsson Askeli, Asger Andersen, Katarina Glise Sandblad...